According to the WHO Remdesivir "increases" the chance of death from Covid19 by 3% and renal failure by 20%. Hundreds of thousands of patients have died since its EUA, but the FDA didn't issue a letter saying Remdesivir does nothing for Covid because it actually does something, it increases your chance of death.

The FDA should give Leronlimab an EUA based on the first 14 days of CD12.